<p>Stress-related neural activity (SNA), as measured by amygdala metabolism, has been linked in prior work to all-cause mortality and major adverse cardiovascular events. In this study, we sought to clarify SNA determinants and test whether age modifies its association with all-cause mortality. Using 2-[18 F]fluoro-2-deoxy-D-glucose positron emission tomography (<sup>18</sup>F-FDG-PET), we quantified amygdala metabolism, a surrogate for SNA, in 1,336 patients (mean age 59.4 ± 15.6 years, 37.8% women). Assessing demographic and imaging confounders, associations between SNA and mortality were evaluated in a subgroup of 960 participants with a median 5-year follow-up (IQR 3–9). Higher SNA appears independently associated with greater all-cause mortality across all age groups (HR 1.45, 95% CI 1.08-1.95; p = 0.012). The association is strongest in younger, healthier individuals (HR 7.86, 95% CI 2.92-21.21; p &lt; 0.001) and attenuates with advancing age. Mediation analysis indicates that SNA accounts for 38.2% (95%&#xa0;CI 15.7%-60.7%) of the age-mortality link. Here, we find that SNA is independently associated with all-cause mortality, with effect sizes that diminish with age; if confirmed, incorporating SNA into risk models alongside conventional factors may improve mortality prediction and help identify younger adults, who appear low risk by standard criteria, for closer follow-up and preventive strategies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Age modulates the link between stress-related neural activity and mortality

  • Nidaa Mikail,
  • Noemi Sablonier,
  • Pimrapat Gebert,
  • Isabelle Glarner,
  • Adriana Vinzens,
  • Achi Haider,
  • Atanas Todorov,
  • Susan Bengs,
  • Angela Portmann,
  • Valerie Treyer,
  • Susanne Wegener,
  • Christoph Gräni,
  • Aju P. Pazhenkottil,
  • Caroline E. Gebhard,
  • Vera Regitz-Zagrosek,
  • Felix C. Tanner,
  • Philipp A. Kaufmann,
  • Ronny R. Buechel,
  • Alexia Rossi,
  • Catherine Gebhard

摘要

Stress-related neural activity (SNA), as measured by amygdala metabolism, has been linked in prior work to all-cause mortality and major adverse cardiovascular events. In this study, we sought to clarify SNA determinants and test whether age modifies its association with all-cause mortality. Using 2-[18 F]fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET), we quantified amygdala metabolism, a surrogate for SNA, in 1,336 patients (mean age 59.4 ± 15.6 years, 37.8% women). Assessing demographic and imaging confounders, associations between SNA and mortality were evaluated in a subgroup of 960 participants with a median 5-year follow-up (IQR 3–9). Higher SNA appears independently associated with greater all-cause mortality across all age groups (HR 1.45, 95% CI 1.08-1.95; p = 0.012). The association is strongest in younger, healthier individuals (HR 7.86, 95% CI 2.92-21.21; p < 0.001) and attenuates with advancing age. Mediation analysis indicates that SNA accounts for 38.2% (95% CI 15.7%-60.7%) of the age-mortality link. Here, we find that SNA is independently associated with all-cause mortality, with effect sizes that diminish with age; if confirmed, incorporating SNA into risk models alongside conventional factors may improve mortality prediction and help identify younger adults, who appear low risk by standard criteria, for closer follow-up and preventive strategies.